Capri Holdings Limited CPRI 深 沪
已收盘 10-31 16:00:00 美东时间
20.75
-0.030
-0.14%
华盛通- 最 高21.02
- 今 开20.67
- 成交量 338.35万股
- 最 低 20.39
- 昨 收 20.78
- 总市值 24.49亿
- 52周最高 26.23
- 市盈率 静 --
- 换手率 2.87%
- 52周最低 11.86
- 委 比 0.00%
- 总股本 1.18亿
- 历史最高 72.37
- 量 比 1.70
- 振 幅 3.03%
- 历史最低 5.42
- 每 手 1
- 风险率 2.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Catalyst Watch - Tesla holder vote on Musk pay; AMD, Palantir earnings
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - November ...
11-01 03:11
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
Capricor Therapeutics announced it will release its third-quarter 2025 financial results on November 10, 2025, followed by a conference call and webcast at 4:30 p.m. ET. The event will discuss financial performance and recent corporate updates. Participants can join via toll-free numbers or webcast. The company, focused on developing cell and exosome-based therapies for rare diseases, is advancing Deramiocel for Duchenne muscular dystrophy and ex...
10-31 13:15
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
10-24 09:51
Jefferies Maintains Hold on Capri Holdings, Raises Price Target to $21
Jefferies analyst Ashley Helgans maintains Capri Holdings (NYSE:CPRI) with a Hold and raises the price target from $19 to $21.
10-24 00:44
Capricorn Metals Ltd Releases 2025 Corporate Governance Statement
Capricorn Metals Ltd ( ($AU:CMM) ) has provided an update. Capricorn Metals Ltd...
10-23 05:52
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
华尔街顶级分析师最新评级报告：高盛遭下调，Coinbase获初始覆盖
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由《The Fly》整理的今日投资者需重点关注的评级动态。 五家获上调评级的公司： 雷...
10-21 21:55
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
DIAMOND BAR, Calif., Oct. 21, 2025 /PRNewswire/ -- The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development...
10-21 20:05
BP confirms oil and gas discovery in Namibia’s offshore Orange Basin
BP (NYSE:BP) on Monday confirmed an oil and gas discovery in Namibia's offshore Orange Basin that African energy explorer and operator Rhino Resources had reported earlier this month, an area where ot...
10-21 04:57
